(Q39381677)

11 September 2017

title

Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil (English)

1 reference

11 September 2017

1 reference

1 reference

G M Mavligit

1

1 reference

11 September 2017

J U Gutterman

2

1 reference

11 September 2017

M A Burgess

3

1 reference

11 September 2017

N Khankhanian

4

1 reference

11 September 2017

G B Seibert

5

1 reference

11 September 2017

J F Speer

6

1 reference

11 September 2017

A V Jubert

7

1 reference

11 September 2017

R C Martin

8

1 reference

11 September 2017

C M McBride

9

1 reference

11 September 2017

E M Copeland

10

1 reference

11 September 2017

E A Gehan

11

1 reference

11 September 2017

E M Hersh

12

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 April 1976

1 reference

11 September 2017

1 reference

11 September 2017

volume

1

1 reference

11 September 2017

issue

7965

1 reference

11 September 2017

page(s)

871-876

1 reference

Cancer of the colon in south saskatchewan.A population study

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: Report of a national veterans administration randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Preoperative irradiation of rectosigmoid carcinoma including its regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

A second look at the second operation in colonic cancer after the administration of fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Fluorouracil as an adjuvant to surgery in carcinoma of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Chemotherapy as an Adjuvant to Surgery for Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer: eight-year progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Management of adult acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Active immunotherapy with B.C.G. for recurrent malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Delay in Progression of Malignant Lymphoma after BCG Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Chemoimmunotherapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Immunotherapy: its possible application in the management of large-bowel cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Demonstration of an Antigen Common to Several Varieties of Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Non-Randomized Controls in Cancer Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Editorial: More blood for the anticoagulant battle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Allocation of subjects in medical experiments.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Amputation and Adriamycin in Primary Osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Concepts for systemic treatment of micrometastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

BCG Immunotherapy of a Rat Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Immunopotentiation with BCG. III. Modulation of the Response to a Tumor-Specific Antigen 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

Carcinoembryonic Antigen and Prognosis in Patients with Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

CEA as a monitor of gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2992093-6

7 January 2021

10.1016/S0140-6736(76)92093-6

Identifiers

DOI

1 reference

11 September 2017

1 reference